Skip Navigation

Rheumatology 2008 47(1):65-67; doi:10.1093/rheumatology/kem283
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Bley, T. A.
Right arrow Articles by Warnatz, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bley, T. A.
Right arrow Articles by Warnatz, K.
Related Collections
Right arrow Diagnostics and Imaging Procedures
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Mural inflammatory hyperenhancement in MRI of giant cell (temporal) arteritis resolves under corticosteroid treatment

T. A. Bley1, M. Markl1, M. Schelp1, M. Uhl1, A. Frydrychowicz1, P. Vaith2, H.-H. Peter2, M. Langer1 and K. Warnatz2

1Department of Diagnostic Radiology and Medical Physics and 2Department of Rheumatology and Clinical Immunology, University Hospital Freiburg, Freiburg, Germany.

Correspondence to: T. A. Bley, Department of Diagnostic Radiology and Medical Physics, University Hospital Freiburg, Hugstetter Strasse 55, 79106 Freiburg, Germany. E-mail: thorsten.bley{at}uniklinik-freiburg.de


  Abstract

Objective. To determine the effect of corticosteroid treatment on mural inflammatory hyperenhancement in MRI in GCA.

Methods. MRI of the superficial temporal artery with sub-millimetre in-plane spatial resolution (195 x 260 µm) was performed in 17 patients with proven GCA at the initiation of corticosteroid treatment and after 16 months of therapy. Visual MRI scores for mural inflammation were correlated with clinical and laboratory findings.

Results. Intensity of inflammatory hyperenhancement decreased significantly under corticosteroid therapy (2.3 ± 0.6 vs 0.5 ± 0.6, P < 0.001, with MRI score >2 indicating vasculitis). This finding correlated with the clinical and serological remission in 15/17 patients. Of the two patients with active disease, one had persisting mural inflammation in MRI indicative of relapsing disease. The other patient presenting with signs of polymyalgia rheumatica had no inflammatory changes of the superficial temporal arteries on MRI scan at follow-up.

Conclusions. Mural contrast enhancement in high-resolution MRI is pronounced in active disease and decreases under corticosteroid treatment, correlating well with laboratory remission.

KEY WORDS: Giant cell arteritis, Steroids, MRI, Vasculitis

Submitted 18 April 2007; revised version accepted 11 September 2007.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.